Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Aurinia Pharmaceuticals Inc, 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Aurinia Pharmaceuticals Inc May 15, 202585.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | Boundless Bio Inc. | Open-market purchase | +249 | $2.40 | $598 |
| Nov 6, 2026 | Boundless Bio Inc. | Open-market purchase | +1,700 | $2.40 | $4,080 |
| Nov 5, 2026 | Boundless Bio Inc. | Open-market purchase | +8,390 | $2.40 | $20,136 |
| Nov 4, 2026 | Boundless Bio Inc. | Open-market purchase | +517 | $2.40 | $1,241 |
| Nov 3, 2026 | Boundless Bio Inc. | Open-market purchase | +2,255 | $2.40 | $5,412 |
| Oct 27, 2026 | Boundless Bio Inc. | Open-market purchase | +10,707 | $2.40 | $25,697 |
| Oct 26, 2026 | Boundless Bio Inc. | Open-market purchase | +9,606 | $2.38 | $22,862 |
| Oct 23, 2026 | Boundless Bio Inc. | Open-market purchase | +6,234 | $2.38 | $14,837 |
| Oct 22, 2026 | Boundless Bio Inc. | Open-market purchase | +5,800 | $2.40 | $13,920 |
| Oct 20, 2026 | Boundless Bio Inc. | Open-market purchase | +220 | $2.37 | $521 |
| Oct 19, 2026 | Boundless Bio Inc. | Open-market purchase | +12,790 | $2.34 | $29,929 |
| Oct 19, 2026 | Boundless Bio Inc. | Open-market purchase | +18,279 | $2.33 | $42,590 |
| Oct 16, 2026 | Boundless Bio Inc. | Open-market purchase | +118,185 | $2.34 | $276,553 |
| Jul 21, 2026 | Boundless Bio Inc. | Open-market purchase | +2,975 | $2.44 | $7,259 |
| Jul 20, 2026 | Boundless Bio Inc. | Open-market purchase | +1,623 | $2.44 | $3,960 |
Questions about Kevin Tang
What boards is Kevin Tang on?
Kevin Tang sits on the board of Aurinia Pharmaceuticals Inc.
What company is Kevin Tang the CEO of?
Kevin Tang is Chief Executive Officer of Aurinia Pharmaceuticals Inc.
How long has Kevin Tang served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.